Final Report Summary - ROBOGYN (Robotic gynaecological brachytherapy)
Objective: We proposed to develop the proof-of-concept prototype of a robotic device to allow for precise implantation of brachytherapy sources into gynaecological cancers with direct magnetic resonance imaging (MRI) guidance.
Activities and results: Functional specification was derived from observation of clinical procedures. Key features were identified and reduced to functions essential to demonstrate feasibility. In this concept, the cervix harbouring the cancer is accessed through the vaginal cavity. The surgical applicator that delivers the brachytherapy needles is manipulated inside the cavity, mimicking conventional manual technique, with a combination of rotations and translations. We designed a new surgical applicator to provide optimal access route to the target anatomy and full coverage of the cancer that often spreads through the uterine wall. We have recreated an ex vivo model of the female anatomy and experimented with different robotic needle driving scenarios with the new surgical applicator and compared its performance to the conventional method. Initial results with the robotic needle driver were promising and showed that friction forces need to be reduced inside the surgical applicator. In order to be able to navigate the surgical applicator with the robot, we developed an automatic method for recovering the full pose (position and orientation) of a brachytherapy ring applicator in magnetic resonance (MR) images, which in turn allows us to compute inverse kinematic commands for the robot to deliver the needles to the target. We implemented the method on the 3D Slicer open-source medical-visualisation and image-analysis platform. The feasibility of applicator pose reconstruction was successfully demonstrated. The registration works robustly on synthetic images with an excellent accuracy and an acceptable execution time. We believe that this system, when fully implemented, will lead to better clinical outcomes by simultaneously improving cancer control and reducing radiation toxicity in surrounding healthy tissues.
Marie Curie Fellow: Gabor Fichtinger, PhD, Queen's University, Canada
Host: Wolfgang Birkfellner, PhD Medical University of Vienna, Austria